Volume 19 Issue 7
Jul.  2021
Turn off MathJax
Article Contents
LUO Wen-ping, LI Xiao-yu, LUO Song, LIU Xiao-lin. Relationship between serum lipoprotein (a) level and CISS classification and severity of ischemic stroke in youth[J]. Chinese Journal of General Practice, 2021, 19(7): 1091-1094, 1102. doi: 10.16766/j.cnki.issn.1674-4152.001992
Citation: LUO Wen-ping, LI Xiao-yu, LUO Song, LIU Xiao-lin. Relationship between serum lipoprotein (a) level and CISS classification and severity of ischemic stroke in youth[J]. Chinese Journal of General Practice, 2021, 19(7): 1091-1094, 1102. doi: 10.16766/j.cnki.issn.1674-4152.001992

Relationship between serum lipoprotein (a) level and CISS classification and severity of ischemic stroke in youth

doi: 10.16766/j.cnki.issn.1674-4152.001992
Funds:

 KJ2019A0364

  • Received Date: 2020-11-25
    Available Online: 2022-02-16
  •   Objective  To explore the relationship between serum lipoprotein (a) [Lp(a)] and ischemic stroke in young people with different Chinese ischemic stroke subtypes (CISS classification), and provide evidence for its prevention and treatment.  Methods  The clinical data of 122 young patients with ischemic stroke treated in the First Affiliated Hospital of Bengbu Medical College from April 2017 to December 2019 were collected and included in the young stroke group, and 122 cases of ischemic stroke patients aged ≥ 45 years who were hospitalised during the same period were randomly admitted as the middle-aged and elderly stroke group. The traditional risk factors and serum Lp(a) levels between the two groups were compared. According to the CISS classification, pathogenesis and NIHSS scores at the time of admission, young patients with ischemic stroke were divided into different groups. The serum Lp(a) levels were compared between the groups. Multivariate logistic regression was used to analyse the independent influencing factors of ischemic stroke in young people.  Results  The serum Lp(a) level in the young stroke group was significantly higher than that in the middle-aged and elderly stroke group (t=7.317, P < 0.001). In different CISS classifications, serum Lp(a) levels in LAA, PAD, CS, OE, and UE groups were (381.38±62.46) mg/L, (297.94±43.97) mg/L, (283.00±39.33) mg/L, (279.25±38.22) mg/L, (292.92±34.93) mg/L, the difference between the groups was statistically significant (F=22.272, P < 0.001). The serum Lp(a) level of the LAA group was significantly higher than that of the PAD group, CS group, OE group and UE group(all P < 0.05), but there was no significant difference among the other four subtypes (all P > 0.05). Moreover, no significant difference was observed in the serum Lp(a) levels amongst patients with different pathogenesis of LAA (F=0.264, P=0.851), but a significant difference was noted in the serum Lp(a) levels amongst patients with different NIHSS scores (F=8.579, P < 0.001). Hyperlipidaemia, smoking and Lp(a)>300 mg/L were independent influencing factors of LAA subtypes in young patients with ischemic stroke.  Conclusion  Elevated serum Lp(a) level is one of the independent risk factors for ischemic stroke in young people. It plays an important role in patients with large atherosclerosis and can be used to assess the severity of the disease. Attention should be paid to monitoring and intervention.

     

  • loading
  • [1]
    中国脑卒中防治报告编写组. 《中国脑卒中防治报告2019》概要[J]. 中国脑血管病杂志, 2020, 17(5): 272-281. doi: 10.3969/j.issn.1672-5921.2020.05.008
    [2]
    HATHIDARA M Y, SAINI V, MALIK A M. Stroke in the young: A global update[J]. Curr Neurol Neurosci Rep, 2019, 19(11): 91. doi: 10.1007/s11910-019-1004-1
    [3]
    MCCARTY J L, LEUNG L Y, PETERSON R B, et al. Ischemic infarction in young adults: A review for radiologists[J]. Radiographics, 2019, 39(6): 1629-1648. doi: 10.1148/rg.2019190033
    [4]
    EKKER M S, BOOT E M, SINGHAL A B, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults[J]. Lancet Neurol, 2018, 17(9): 790-801. doi: 10.1016/S1474-4422(18)30233-3
    [5]
    CAPRIO F Z, SOROND F A. Cerebrovascular disease: Primary and secondary stroke prevention[J]. Med Clin North Am, 2019, 103(2): 295-308. doi: 10.1016/j.mcna.2018.10.001
    [6]
    ROLFS A, FAZEKAS F, GRITTNER U, et al. Acute cerebrovascular disease in the young: The stroke in young fabry patients study[J]. Stroke, 2013, 44(2): 340-349. doi: 10.1161/STROKEAHA.112.663708
    [7]
    SHAH N P, PAJIDIPATI N J, MCGARRAH R W, et al. Lipoprotein (a): An update on a marker of residual risk and associated clinical manifestations[J]. Am J Cardiol, 2020, 126(13): 94-102. http://www.sciencedirect.com/science/article/pii/S0002914920303325
    [8]
    付瀚辉, 彭斌. 脂蛋白(a)在缺血性卒中中的作用研究[J]. 中国脑血管病杂志, 2019, 16(6): 327-331. doi: 10.3969/j.issn.1672-5921.2019.06.009
    [9]
    彭斌, 吴波. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. doi: 10.3760/cma.j.issn.1006-7876.2018.09.004
    [10]
    BOOT E, EKKER M S, PUTAALA J, et al. Ischaemic stroke in young adults: A global perspective[J]. J Neurol Neurosurg Psychiatry, 2020, 91(4): 411-417. doi: 10.1136/jnnp-2019-322424
    [11]
    朱琳, 姚明, 周立新, 等. 青年缺血性卒中病因诊断的性别差异研究[J]. 中风与神经疾病杂志, 2020, 37(8): 689-693. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFSJ202008005.htm
    [12]
    王力, 何晓芬, 王力锋, 等. 青年脑梗死患者危险因素及病因学分型分析[J]. 中国医药, 2019, 14(8): 1173-1176. doi: 10.3760/j.issn.1673-4777.2019.08.013
    [13]
    虞美慧, 韩丽雅, 朱丽娟, 等. 186例青年脑卒中患者临床病因及危险因素分析[J]. 中华全科医学, 2015, 13(6): 1007-1009. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201506053.htm
    [14]
    NAVE A H, LANGE K S, LEONARDS C O, et al. Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis[J]. Atherosclerosis, 2015, 242(2): 496-503. doi: 10.1016/j.atherosclerosis.2015.08.021
    [15]
    FERRETTI G, BACCHETTI T, JOHNSTON T P, et al. Lipoprotein (a): A missing culprit in the management of athero-thrombosis?[J]. J Cell Physiol, 2018, 233(4): 2966-2981. doi: 10.1002/jcp.26050
    [16]
    MELLWIG K P, VOGT A. Lipoprotein (a)[J]. Clin Res Cardiol Suppl, 2019, 14(Suppl 1): 1-4.
    [17]
    PIRRO M, BIANCONI V, PACIULLO F, et al. Lipoprotein (a) and inflammation: A dangerous duet leading to endothelial loss of integrity[J]. Pharmacol Res, 2017, 119(5): 178-187. http://www.onacademic.com/detail/journal_1000039818731810_f28b.html
    [18]
    LANGSTED A, NORDESTGAARD B G, KAMSTRUP P R. Elevated lipoprotein (a) and risk of ischemic stroke[J]. J Am Coll Cardiol, 2019, 74(1): 54-66. doi: 10.1016/j.jacc.2019.03.524
    [19]
    GAO S, WANG Y J, XU A D, et al. Chinese ischemic stroke subclassification[J]. Front Neurol, 2011, 2(6): 1-5. http://doaj.org/article/7238bb1cb9024cdf9b295bea40552eb5
    [20]
    TAN S, ZHANG L, CHEN X, et al. Comparison of the Chinese ischemic stroke subclassification and Trial of Org 10172 in acute stroke treatment systems in minor stroke[J]. BMC Neurol, 2016, 16(1): 162. doi: 10.1186/s12883-016-0688-y
    [21]
    ZHANG H, LI Z, DAI Y, et al. Ischaemic stroke etiological classification system: The agreement analysis of CISS, SPARKLE and TOAST[J]. Stroke Vasc Neurol, 2019, 4(3): 123-128. doi: 10.1136/svn-2018-000226
    [22]
    郭升, 殷闯, 苏祯磊, 等. 青年缺血性脑卒中类肝素药物治疗急性缺血性脑卒中试验分型与中国缺血性卒中亚型分型比较[J]. 新乡医学院学报, 2017, 34(3): 194-196. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYX201703010.htm
    [23]
    冯志霞, 许哲通, 吕志坤, 等. 200例青年脑梗死患者CISS分型与高同型半胱氨酸的关系[J]. 中风与神经疾病杂志, 2016, 33(3): 242-244. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFSJ201603013.htm
    [24]
    陈永明, 王慧玲. 大动脉粥样硬化型脑梗死发病机制、主要危险因素及预后影响因素的研究进展[J]. 实用心脑肺血管病杂志, 2018, 26(10): 6-9. https://www.cnki.com.cn/Article/CJFDTOTAL-SYXL201810006.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(6)

    Article Metrics

    Article views (174) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return